Rocket Pharmaceuticals
RCKT
RCKT
175 hedge funds and large institutions have $1.83B invested in Rocket Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 44 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
21% more capital invested
Capital invested by funds: $1.52B → $1.83B (+$315M)
16.12% more ownership
Funds ownership: 94.9% → 111.02% (+16%)
7% more funds holding
Funds holding: 164 → 175 (+11)
Holders
175
Holding in Top 10
7
Calls
$24.7M
Puts
$7.61M
Top Buyers
| 1 | +$59M | |
| 2 | +$35.3M | |
| 3 | +$28.7M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$25.6M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
+$25.6M |
Top Sellers
| 1 | -$23.8M | |
| 2 | -$18.7M | |
| 3 | -$8.58M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.74M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.87M |